Literature DB >> 19880683

71-year-old man with chronic kidney failure and sudden change of mental status.

Aaron S Mansfield1, Qi Qian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19880683      PMCID： PMC2770914          DOI： 10.1016/S0025-6196(11)60673-3

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  13 in total

Review 1.  Structure and regulation of voltage-gated Ca2+ channels.

Authors:  W A Catterall
Journal:  Annu Rev Cell Dev Biol       Date:  2000       Impact factor: 13.827

Review 2.  Functional interactions between presynaptic calcium channels and the neurotransmitter release machinery.

Authors:  J David Spafford; Gerald W Zamponi
Journal:  Curr Opin Neurobiol       Date:  2003-06       Impact factor: 6.627

3.  Gabapentin and behavioral disorders in severe Alzheimer disease.

Authors:  Francesco Raudino; M G Mascalzi; A Zagami
Journal:  J Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.153

4.  Gabapentin-induced coma in a patient with renal failure.

Authors:  Ayhan Dogukan; Bilge Aygen; Muhammed S Berilgen; Sait Dag; Sevim Bektas; Ali I Gunal
Journal:  Hemodial Int       Date:  2006-04       Impact factor: 1.812

5.  Saturable transport of gabapentin at the blood-brain barrier.

Authors:  M S Luer; C Hamani; M Dujovny; B Gidal; M Cwik; K Deyo; J H Fischer
Journal:  Neurol Res       Date:  1999-09       Impact factor: 2.448

6.  All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan.

Authors:  Chi Pang Wen; Ting Yuan David Cheng; Min Kuang Tsai; Yen Chen Chang; Hui Ting Chan; Shan Pou Tsai; Po Huang Chiang; Chih Cheng Hsu; Pei Kun Sung; Yi Hua Hsu; Sung Feng Wen
Journal:  Lancet       Date:  2008-06-28       Impact factor: 79.321

7.  Differential modulation of K(+)-evoked (3)H-neurotransmitter release from human neocortex by gabapentin and pregabalin.

Authors:  B Brawek; M Löffler; D J Dooley; A Weyerbrock; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-12       Impact factor: 3.000

8.  Disposition of gabapentin in anuric subjects on hemodialysis.

Authors:  M O Wong; M A Eldon; W F Keane; D Türck; H N Bockbrader; B A Underwood; A J Sedman; C E Halstenson
Journal:  J Clin Pharmacol       Date:  1995-06       Impact factor: 3.126

9.  Pharmacokinetics of gabapentin in subjects with various degrees of renal function.

Authors:  R A Blum; T J Comstock; D A Sica; R W Schultz; E Keller; P Reetze; H Bockbrader; D Tuerck; J A Busch; P A Reece
Journal:  Clin Pharmacol Ther       Date:  1994-08       Impact factor: 6.875

10.  Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.

Authors:  Mark J Field; Peter J Cox; Emma Stott; Heather Melrose; James Offord; Ti-Zhi Su; Steve Bramwell; Laura Corradini; Steven England; Joanna Winks; Ross A Kinloch; Jan Hendrich; Annette C Dolphin; Tony Webb; Dic Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205
View more
  1 in total

1.  Gabapentin and Pregabalin Use and Association with Adverse Outcomes among Hemodialysis Patients.

Authors:  Julie H Ishida; Charles E McCulloch; Michael A Steinman; Barbara A Grimes; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2018-06-05       Impact factor: 10.121
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.